GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tonix Pharmaceuticals Holding Corp (STU:TPM0) » Definitions » 1-Year ROIIC %

Tonix Pharmaceuticals Holding (STU:TPM0) 1-Year ROIIC % : 90.84% (As of Mar. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Tonix Pharmaceuticals Holding 1-Year ROIIC %?

1-Year Return on Invested Incremental Capital (1-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 1-year. Tonix Pharmaceuticals Holding's 1-Year ROIIC % for the quarter that ended in Mar. 2024 was 90.84%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for Tonix Pharmaceuticals Holding's 1-Year ROIIC % or its related term are showing as below:

STU:TPM0's 1-Year ROIIC % is ranked better than
74.49% of 1462 companies
in the Biotechnology industry
Industry Median: -4.78 vs STU:TPM0: 90.84

Tonix Pharmaceuticals Holding 1-Year ROIIC % Historical Data

The historical data trend for Tonix Pharmaceuticals Holding's 1-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tonix Pharmaceuticals Holding 1-Year ROIIC % Chart

Tonix Pharmaceuticals Holding Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
1-Year ROIIC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -249.60 -158.17 -99.59 -44.73 -34.32

Tonix Pharmaceuticals Holding Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
1-Year ROIIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -87.31 -3,329.73 -64.78 -34.32 90.84

Competitive Comparison of Tonix Pharmaceuticals Holding's 1-Year ROIIC %

For the Biotechnology subindustry, Tonix Pharmaceuticals Holding's 1-Year ROIIC %, along with its competitors' market caps and 1-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tonix Pharmaceuticals Holding's 1-Year ROIIC % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Tonix Pharmaceuticals Holding's 1-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where Tonix Pharmaceuticals Holding's 1-Year ROIIC % falls into.



Tonix Pharmaceuticals Holding 1-Year ROIIC % Calculation

Tonix Pharmaceuticals Holding's 1-Year ROIIC % for the quarter that ended in Mar. 2024 is calculated as:

1-Year ROIIC %=1-Year Incremental Net Operating Profit After Taxes (NOPAT)**/1-Year Incremental Invested Capital
=( -97.847 (Mar. 2024) - -114.522 (Mar. 2023) )/( 102.04 (Mar. 2024) - 89.477 (Mar. 2023) )
=16.675/12.563
=132.73%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** TTM data of NOPAT and Invested Capital was used to calculate 1-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


Tonix Pharmaceuticals Holding  (STU:TPM0) 1-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


Tonix Pharmaceuticals Holding 1-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of Tonix Pharmaceuticals Holding's 1-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Tonix Pharmaceuticals Holding (STU:TPM0) Business Description

Traded in Other Exchanges
Address
26 Main Street, Suite 101, Chatham, NJ, USA, 07928
Tonix Pharmaceuticals Holding Corp is a clinical-stage biopharmaceutical company focused on developing therapeutics and vaccines to treat and prevent human disease and alleviate suffering. its portfolio consists of the central nervous system, rare disease, immunology, and infectious disease product candidates. The CNS portfolio includes small molecules and biologics to treat pain, neurologic, psychiatric, and addiction conditions. CNS product candidate is TNX-102 SL, a proprietary sublingual tablet formulation of cyclobenzaprine (CBP) designed for bedtime administration.

Tonix Pharmaceuticals Holding (STU:TPM0) Headlines

No Headlines